The current research & development by business enterprise, pharmaceutical industry in constant ppp $ in Denmark is 1,310.07 million, which has increased by 154.92 million (13.4%) since 2019.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Denmark
No matching regions
Similar regions to Denmark
Business R&D pharmaceutical in constant PPP $
More indicators for Denmark
Government R&D in security as % of government support
0.32%
+0.02%
(2021)
Higher-education-finacing R&D financed by general university in local currency
129,580.00M
+1,780.00M
(2020)
R&D financed by rest of the world in local currency
37,780.00M
-21,180.00M
(2019)
Government R&D financed by rest of the world in local currency
2,450.00M
-310.00M
(2020)
Business R&D financed by rest of the world in local currency
12,950.00M
-22,140.00M
(2019)
Non-profit R&D growth rate
-20.37%
-18.37%
(2022)
Denmark Business R&D pharmaceutical in constant PPP $ between 2009 and 2020
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2020 | 1,310.07M | +154.92M |
| 2019 | 1,155.15M | -91.98M |
| 2018 | 1,247.14M | -57.86M |
| 2017 | 1,305.00M | -130.33M |
| 2016 | 1,435.33M | +196.65M |
| 2015 | 1,238.68M | +67.36M |
| 2014 | 1,171.32M | +19.84M |
| 2013 | 1,151.47M | +21.72M |
| 2012 | 1,129.75M | +174.07M |
| 2011 | 955.68M | -64.11M |
| 2010 | 1,019.80M | +43.95M |
| 2009 | 975.85M |